EDITOR’S EMULSION

 

PATIENT SAFETY CAPSULES

 

DRUG LAWS & POLICY INJECTIONS

 

PHARMA INJECTIONS

 

DRUG DOPES

 

NATIONAL INJECTIONS

 

GLOBAL INJECTIONS

 

PSAIIF PILL

 

DOSE OF THE DAY

 

FAQ

 

SUBSCRIBER'S SYMPTOM

 

UPCOMING EVENTS

 

LAUGHTER DOSE

 

SUBSCRIPTION AND SPONSORSHIP

 

CONTACT US

 

News Archive

EDITOR'S EMULSION

Warm Greetings!!!

Welcome to yet another interesting and informative edition of our newsletter!

It has been my privilege to reach you on the 1st & 17th of every month for the last 13 years. Please feel free to share your comments on this edition to enable us to improve constantly. In case you have missed any of our previous issues, you can find them on our website www.jagograhakjago.com or in the News Archive section of every issue of The Prescription. You can also look us up on Facebook.

Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief

DOSE OF THE DAY

"Gift of life is the ultimate gift that one could give and organ donation is, therefore, a God like act."

Smt. Anupriya Patel MoS for Health and Family Welfare, Government of India

PATIENT SAFETY CAPSULES

Financial strain of disability in India high, insurance aims to bridge gap

Aug 11,2024: According to experts, close to 5 to 7 lakh people in the country suffer from temporary or permanent disability each year due to the high rates of accidents and crippling diseases and lose their ability to work and earn a livelihood. Read More...

AIIMS Rajkot now self-sufficient for virus detection: Union Health Minister JP Nadda

Aug 11,2024: "Earlier, this institute (AIIMS Rajkot) was dependent on NIV (National Institute of Virology) Pune for virus detection, now it is self-sufficient for virus detection. PM Modi envisioned providing tertiary (higher-end) healthcare facilities to the common people," said JP Nadda after visiting AIIMS. Read More...

 

DRUG LAWS & POLICY INJECTIONS

India waives clinical trial requirement for drugs approved in developed markets

Aug 08,2024: After this, a proposal to include the EU for medical devices was sent to the health ministry. However, it was referred back to the CDSCO for critical review in the context of updated rules and recent notifications. The ministry also asked for deliberations in consultation with the Drug Technical Advisory Board for a fresh proposal. Read More...

DCGI frames guidelines to ensure product traceability

Aug 12,2024: The Drugs Controller General of India (DCGI), the country's top drug regulator, has framed standard operating procedure and guidelines to ensure product traceability throughout the supply chain, as the menace of fake and spurious medicines grows. Read More...

Sperm or egg donor has no legal right on child, can't claim to be biological parent: HC

Aug 13,2024: "Under the guideline, it is clearly stated that the sperm/oocyte (egg) donor shall not have parental rights or duties in relation to the child and in that view of the matter, the younger sister of the petitioner can have no right whatsoever to intervene and claim to be the biological mother of the twin daughters," the high court said. Read More...

Patanjali Misleading Ads Case: SC comes down heavily on IMA over inadequate apology

Aug 06,2024: The counsel for IMA, PS Pathwalia, informed the bench that the interview in question was given to the Press Trust of India (PTI). On this, Justice Kohli questioned Pathwalia regarding the scope of the apology. "Besides the ones you are referring to, which other publications was it [the interview] shared with? You have to send [the apology] to all of them. Read More...

 

PHARMA INJECTIONS

Mosquitoes bite into health insurance claims

Aug 10,2024: According to a study of reported health insurance claims by Policybazaar, vector borne diseases like Dengue and Malaria account for 15% of total seasonal illnesses claims. The cost for treating these mosquito-borne diseases typically ranges from Rs 50,000 to Rs 1,50,000. These claims surge in July and August when humid conditions create ideal breeding grounds for mosquitoes. Read More...

Delhi High Court urges quick decision on Mankind Pharma's plea against Mercykind Pharmaceuticals

Aug 14,2024: A bench led by Justice Yashwant Varma said that “although we are informed that during the pendency of the present appeal, the defendant (Tiwari) has made significant changes both in its logo and get up of products which are being marketed by it, in our considered opinion, these and other issues which arise would clearly merit consideration afresh by the learned single judge.” Read More...

India achieves milestone with completion of 32 pharma projects under PLI scheme

Aug 10,2024: According to the Ministry, the scheme received an overwhelming response, with 249 applications submitted for consideration. Out of these, 48 projects have been selected for the manufacturing of identified bulk drugs, with 13 projects being implemented by 10 Micro, Small, and Medium Enterprises (MSMEs). The completion of 32 projects marks a critical step forward, with the remaining 16 projects still under development, read the press release. Read More...

Waiver of clinical trials to compromise patient safety: Trade research body

Aug 13,2024: In less than a week since the Drugs Controller General of India (DCGI) has given permission to pharma companies to launch certain types of drugs without local clinical trials, the economic think tank GTRI (Global Trade Research Initiative) has opposed the decision. Read More...

DRUG DOPES

Govt plans crackdown on lookalike drug brands

Indian salt and sugar brands have microplastics: Toxics Link Study

Karnataka DC working to attain top spot in implementation of drug regulations

NATIONAL INJECTIONS

Alembic gets USFDA nod for generic medication

Twenty two thousand Mankind Pharma employees unite in ground-breaking organ donation awareness drive

Pre-approved by WHO, Qdenga dengue vaccine shows 50 pc efficacy, lasting effects: Study

 

GLOBAL INJECTIONS

Lupin completes phase 3 study of LUBT010, a biosimilar candidate to Lucentis

Aug 05,2024: Global pharma major Lupin Limited (Lupin) announced the successful completion of a global phase 3 clinical study of LUBT010, its biosimilar candidate to Lucentis. Read More...

 

China NMPA grants Breakthrough Therapy Designation to Mabwell's novel Nectin-4 targeting ADC 9MW2821

Atul Bioscience receives EIR report from US FDA

 

PSAIIF PILL

We must ensure protective environment for children with disabilities: Chhattisgarh HC Chief Justice Ramesh Sinha

Aug 11,2024: The Chief Justice also deliberated upon the need for sensitization and awareness among various stakeholders and common people regarding the Medical Termination of Pregnancy (MTP) Act to ensure that rape victims receive quick and necessary assistance for the termination of pregnancy caused due to rape. Read More...

DCGI brings sterile equipment manufacturers under GMP ambit

Aug 13,2024: The Central Drugs Standard Control Organization (CDSCO) has directed makers of sterile equipment to comply with Schedule M of the Drugs and Cosmetic Rule, which mandates companies to follow Good Manufacturing Practices (GMP) at par with the World Health Organization (WHO) standards. Read More...

 FREQUENTLY ASKED QUESTIONS

How much salt is too much salt?

Aug 04,2024: While fundamental nutrition schemes such as the Universal Salt Iodization Program (providing fortified salt – with both iodine and iron to address anaemia), the Mid-Day Meal scheme, and the Public Distribution System have made significant strides in ensuring adequate nutritional intake among Indians (specifically children), a multifaceted approach is crucial to effectively alter behavioural patterns and encourage healthy dietary habits. Read More...

SUBSCRIBER'S SYMPTOM

Rare disease patients suffer as CoEs underutilise funds, shows data

July 30,2024: Five out of 12 Centres of Excellence (COEs) formed to treat patients suffering from rare diseases have utilised less than 35 per cent of the funds allotted to them by the Centre over the last three years, according to patient advocacy groups and data from a reply given in Parliament. Read More...

ICMR, Panacea Biotec begin Phase 3 clinical trial of indigenous dengue vaccine

Aug 14,2024: The tetravalent dengue vaccine strain (TV003/TV005), initially developed by the National Institutes of Health (NIH) in the USA, has demonstrated promising results in global preclinical and clinical trials. In India, Phase 1 and 2 trials of the vaccine formulation were completed in 2018-19 with positive outcomes, according to Union Health Ministry. Read More...

UPCOMING EVENTS

World Neurosciences Summit 2024

23 - 25 Aug 2024, JW Marriott, Aerocity, New Delhi, India

Know more

Fitness India 2024 

29 - 31 Aug 2024, Pragati Maidan, New Delhi, India

Know more

 Indian Pharma Expo 2024 

30 - 31 Aug 2024, Pragati Maidan, New Delhi, India

Know more

LAUGHTER DOSE

SUBSCRIPTION AND SPONSORSHIP

Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
www.jagograhakjago.com
Disclaimer: Our newsletter endeavors to compile patient safety information from various sources. PSAIIF may not be held responsible for any article published in The Prescription.

We request our esteemed readers to write to us at bejonmisra@jagograhakjago.com with your feedback and suggestions on what you would like us to feature in the newsletter.